Core Viewpoint - Mediterranean anemia is a common hereditary blood disorder that affects red blood cell production, leading to anemia symptoms. Early screening and preventive measures can significantly reduce the risk of children inheriting the disease from parents [1]. Group 1: What is Mediterranean Anemia? - Mediterranean anemia is caused by genetic mutations and is classified into two types: α-thalassemia and β-thalassemia. It affects hemoglobin synthesis, resulting in symptoms such as anemia, fatigue, and decreased immunity [2]. - α-thalassemia is due to the deletion or mutation of the α-chain gene, leading to varying degrees of anemia and potential complications like liver and spleen enlargement [2]. - β-thalassemia results from defects in the β-chain gene, causing severe anemia and symptoms like jaundice and skeletal deformities [2]. Group 2: Genetic Inheritance of Mediterranean Anemia - Mediterranean anemia follows an autosomal recessive inheritance pattern, meaning that both parents must carry the gene for their child to be affected. If only one parent is a carrier, the child is typically healthy but may be a carrier [3][4]. Group 3: Symptoms and Hazards of Mediterranean Anemia - Common symptoms include fatigue, dizziness, and pallor [5]. - Patients may experience liver and spleen enlargement, which can impair organ function [6]. - Severe cases, particularly of β-thalassemia, may lead to skeletal deformities and short stature [7]. - Long-term anemia can weaken the immune system, increasing susceptibility to infections [8]. Group 4: Importance of Prenatal Prevention - Prenatal prevention is crucial as it allows parents to determine if they are carriers of the Mediterranean anemia gene through screening. This knowledge enables them to take measures to reduce the risk of having an affected child [9]. Group 5: Recommended Prenatal Checks - Genetic screening for Mediterranean anemia is essential to identify if either parent is a carrier. This typically includes tests for both α and β-thalassemia genes [10][11]. - A complete blood count can help detect anemia, although carriers may not show obvious symptoms [11]. - Iron level testing is important to rule out iron deficiency anemia, which can exacerbate symptoms [11]. - A comprehensive health assessment for both parents is recommended to ensure overall health before pregnancy [11]. Group 6: Preventing the Birth of Affected Children - Couples can reduce the risk of having a child with Mediterranean anemia through genetic screening and counseling. If both parents are carriers, they may consider pre-implantation genetic diagnosis [12]. - Choosing a partner who is not a carrier can significantly lower the chances of having an affected child [12]. - Early detection and intervention during pregnancy, such as amniocentesis or non-invasive DNA testing, are crucial if there is a risk of the fetus having the condition [12]. Conclusion - Mediterranean anemia, as a hereditary disease, can be effectively prevented through prenatal genetic screening and early intervention. Understanding genetic carrier status and taking necessary precautions can greatly reduce the risk of having an affected child, emphasizing the importance of prenatal checks for prospective parents [13].